This careful plan is there so patients stay safe and get good results
Weight loss was associated with a lower likelihood of stopping treatment, while gastrointestinal adverse events increased discontinuation risk
Contact your doctor to evaluate the symptom properly, especially if it persists or worsens
While less common, men can also develop UTIs related to sexual activity
However, its always a good idea to follow any specific instructions provided by your healthcare provider to ensure youre fully prepared for your treatment
A temporary Medicare GLP-1 Bridge program now covers Wegovy, Zepbound, and Foundayo at $50/month through December 31, 2027, but retatrutide isn't expected to be approved until late 2027 at the earliest, meaning it will likely miss this window